Investigate The Clinical Effect Of Qingfeihuatan Decoction In The Treatment Of Community Acquired Pneumonia Patients With Stagnation Of Phlegm-heat In The Lung Type

Objective:To investigate the clinical effect of QingFeiHuaTan decoction in the treatment of community acquired pneumonia (CAP) patients with Stagnation of phlegm-heat in the lung Type by the method of randomized controlled clinical trial design, which affected the changes of clinical symptom, sign, white blood cell(WBC), procalcitonin(PCT), C-reactive protein(CRP), absorption of Lung shadow in each group before and after treatment, and evaluate the clinical efficacy of QingFeiHuaTan decoction for treatment of CAP patients.Method:In strict accordance with the inclusion and exclusion standard, we selected 60 CAP patients, and divided them into treatment group and control group by using randomized controlled clinical trial design method,30 cases in each group. Among them, the patients of control group only take conventional therapy of the western medicine. The patients of treatment of treatment group treaded with QingFeiHuaTan decoction and western medicine. The period of treatment was 12 days. After analyzed all the data by statistical software, observed the clinical symptom and sign, the level of WBC, PCT, CRP, absorption of Lung shadow of the groups of patients before and after treatment.Result:1. After treatment, the treatment group of traditional Chinese medicine treatment efficiency is higher than the control group, the difference was statistically significant (P<0.05).2. After treatment, the treatment group of TCM syndrome improvement is better than the control group, the difference is statistically (P<0.05).3. After treatment, the WBC,PCT,CRP in the treatment group were better than those in the control group, the difference was statistically significant (P<0.05).4. After treatment, the effective rate of pulmonary shadow absorption in the treatment group was higher than that in the control group, the difference was statistically significant (P< 0.05).5. There was no drug allergy and other serious adverse reactions.Conclusion:QingFeiHuaTan decoction combined with conventional western medicine therapy can effectively improve the clinical symptoms of CAP patients with Stagnation of phlegm-heat in the lung Type, and reduce the levels of inflammation such as WBC, CRP and PCT.